Final Report on the Safety Assessment of Cocoyl Sarcosine,Lauroyl Sarcosine,Myristoyl Sarcosine,Oleoyl Sarcosine,Stearoyl Sarcosine,Sodium Cocoyl Sarcosinate,Sodium Lauroyl Sarcosinate,Sodium Myristoyl Sarcosinate,Ammonium Cocoyl Sarcosinate,and Ammonium Lauroyl Sarcosinate

Abstract

This safety assessment addresses cosmetic ingredients that are N-acyl derivatives of sarcosine and are generally referred to as acyl sarcosines, and those that are salts, known generally as acyl sar-cosinates. Previous assessments have addressed the safety of each of the fatty acids that appear in these acyl sarcosines and sarcosinates (Coconut Acid, Oleic Acid, Lauric Acid, and Myristic Acid). In each case the fatty acid was either safe for use or safe as used in cosmetic formulations. Acyl sarcosines are considered modified fatty acids with greater solubility and increased acidity of the carboxylic acid group compared to the parent fatty acid. They are used in a large number of cosmetic formulations as hair-conditioning agents and surfactant-cleansing agents. In soaps, concentrations are reported to be as high as 12.9%. These ingredients have low oral toxicity in rats. Although cytotoxic to Chinese hamster cells in culture, acyl sarcosines and sarcosinates are not mutagenic in those cells, nor in bacterial cells in culture. Carcinogenicity data were not available. These ingredients are nonirritating and nonsen-sitizing to animal and human skin, although they can enhance the penetration of other ingredients through the skin. For that reason, caution should be exhibited in formulating cosmetic products that contain these ingredients in combination with other ingredients whose safety is based on their lack of absorption or where dermal absorption is a concern (e.g., HC Yellow No. 4, Disperse Yellow 3). Because sarcosine can be nitrosated to form N-nitrososarcosine, a known animal carcinogen, these ingredients should not be used in cosmetic products in which N-nitroso compounds may be formed. With the above caveat, and based on the available data, it was concluded that these acyl sarcosines and sarcosinates are safe as used in rinse-off products. They may be safely used in leave-on products at concentrations up to 5%, the highest concentration tested in clinical irritation and sensitization studies. Oleoyl Sarcosine is used as a corrosion inhibitor in some aerosol products, at extremely low concentrations. In this circumstance, the ingredient is not being used as a cosmetic ingredient and this report is not intended to limit that use. Because of the absence of data on inhalation toxicity, however, it was concluded that the available data were not sufficient to support the safety of acyl sarcosines and sarcosinates as cosmetic ingredients in products where they are likely to be inhaled.

References

Aioi, A.

K. Kuriyama

T. Shimizu

M. Yoshioka

, and

S. Uenoyama

. 1993. Effects of vitamin E and squalene on skin irritation of a transdermal absorption enhancer, lauroylsarcosine. Int. J. Pharm.93:1–6.

Aldrich Chemical Co

. 1992. Catalog hardbook of fine chemicals, 1099. Milwaukee, WI: Aldrich Chemical Co.

Anderson, I. E.

A. J. Herring

G. E. Jones

, and

J. C. Low

. 1995. Development and evaluation of an indirect ELISA to detect antibodies to abortion strains of Chlamydia psittaci in sheep sera. Vet. Microbiol.43:1–12.

Bauer, C. W.

, and

E. F. La Sala

. 1956. The effect of sodium N-lauroyl sarcosinate and of sodium dehydroacetate on the enzymes of the gastrointestinal tract. J. Am. Pharm. Assoc.45:675–678.

Bettley, F. R.

1965. The influence of detergents and surfactants on epidermal permeability. Br. J. Dermatol.77:98–100.

Blevins, R. D.

, and

D. E. Taylor

. 1982. Mutagenicity screening of twenty-five cosmetic ingredients with the Salmonella/microsome test. J. Environ. Sci. HealthA17:217–239.

Carbon, J. A.

R. Q. Blackwell

J. C. Calandra

, and

L. S. Fosdick

. 1954. The inhibition of anaerobic glycolysis by sodium N-lauroyl sarcosinate. Arch. Biochem.55:356–364.

Chemline

. 1996. Chemline database. Bethesda, MD: National Library of Medicine.

Consumer Product Safety Commission

. 1986. Federal Hazardous Substances Act Regulations. Code of Federal Regulations. Title 16, Subchapter IIC. Part 1500.41. Washington, DC: Office of the Federal Register.

10.

Elder, R. L.

, ed. 1986. Final Report on the Safety Assessment of Coconut Oil, Coconut Acid, Hydrogenated Coconut Acid, and Hydrogenated Coconut Oil. J. Am. Coll. Toxicol.5:103–121.

11.

Elder, R. L.

, ed. 1987. Final Report on the Safety Assessment of Oleic Acid, Lauric Acid Palmitic Acid, Myristic Acid, and Stearic Acid. J. Am. Coll. Toxic.6:321–401.

12.

FDA

. 1998. Frequency of use of cosmetic ingredients. FDA database.Washington, DC: FDA.

13.

Food and Drug Research Laboratories

. 1989. Hamposyl M-30-Primary Skin Irritation of Hamposyl M-30 in New Zealand White Rabbits. Unpublished data submitted by Hampshire Chemical Corporation, 5-27–97. (26 pages.)2

14.

French, I. W.

J. J. Stock

, and

F. A. Morrison

. 1958. The development of “anti-enzyme” resistance by Lactobacillus acidophilus. Can. Pharm. J. Sci.91:540–544.

15.

Frosch, P. J.

, and

A. M. Kligman

. 1979. The soap chamber test. J. Am. Acad. Dermatol.1:35–41.

16.

Geigy Chemical Corp. No date. Properties of Sarkosyl NL-30. Submitted by FDA in response to an FOI request on PEGs Dilaurate dated 10-25–96. (14 pages.)

17.

Geigy Industrial Chemicals

. 1958. Technical bulletin on N-acyl sarcosine surfactants. Submitted by FDA in response to an FOI request dated 5-14–96. (16 pages.)

18.

Geigy Industrial Chemicals

. 1962. Technical bulletin on N-acyl sarcosine surfactants. Submitted by FDA in response to an FOI request dated 5-14–96. (16 pages.)

19.

Grant, J.

, ed. 1972. Hackh's chemical dictionary, 4th ed., 598. New York: McGraw-Hill.

20.

Hampshire Chemical Corporation

. 1997a. Petition to Environmental Protection Agency (EPA) to exempt N-acyl sarcosines and their salts from need of tolerance and Hampshire hamposyl surfactants, 5th ed. (brochure). With cover letter, dated 5-27–97. (50 pages.)2

21.

Hampshire Chemical Corporation

. 1997b. Cosmetic use of acyl sarcosines and sarcosinates. Correspondence dated 10-1–97. (1 page.)2

22.

Hart. J. R.

1979. N-acyl sarcosine surfactants. Cosmet. Toiletries94:74–76.

23.

Hartmann, A

., and

G. Speit

. 1997. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol. Lett.90:183–188.

24.

Hassell, T. M.

, and

H. R. MuUhlemann

. 1971. Effects of sodium N-lauroyl sarcosinate on plaque pH in vivo. Helv. Odont. Acta15:52–53.

25.

International Agency for Research on Cancer (IARC)

. 1978. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some N-Nitroso compounds, vol. 17, 327–336. Lyon: IARC.

26.

IARC

. 1987. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, suppl. 7. Overall evaluations of carcinogenicity: An updating of IARC monographs vol. 1-42, 68. Lyon: IARC.

27.

Kippert, F

. 1995. A rapid permeabilization procedure for accurate quantitative determination of beta-galactosidase activity in yeast cells. FEMS Microbiol. Lett.128:201–206.

28.

Koontongkaew, S

., and

S. Jitpukdeebodintra

. 1995. Interaction of chlorhexidine with cytoplasmic membranes of Streptococcus mutans GS-5. Caries Res.29:413–417.

29.

Lewis, R. J., Sr.

, ed. 1997. Hawley's condensed chemical dictionary, 13th ed., 286, 984. New York: Van Nostrand Reinhold.

30.

Mefford, I. N.

1987. Lauroyl sarcosine: A weak cation-exchange reagent for on-column modification of reversed-phase material. J. Chromatogr.393:441–446.

31.

Molever, K

. 1993. Quantitative determination of sodium lauroyl sarcosinate by gas chromatography. J. Am. Oil Chem. Soc.70:101–103.

32.

National Toxicology Program (NTP)

. 1994. Seventh Annual Report on Carcinogens (Summary), 306–308. Reseach Triangle Park, NC: NTP.

33.

Nelson, M. F.

, and

D. Stewart

, Jr. 1956. The absorption of N-acyl sarcosines on various protein materials. J. Soc. Cosm. Chem.7:22–31.

34.

Newton, J. C.

W. T. Blevins

G. R. Wilt

, and

L. G. Wolfe

. 1990. Outer membrane protein profiles of Edwardsiella ictaluri from fish. Am. J. Vet. Res.51:211–215.

35.

Nikitakis, J. M.

, and

G. N. McEwen

, Jr., ed. 1990. CTFA compendium of cosmetic ingredient composition—Descriptions I. Washington, DC: The Cosmetic, Toiletry, and Fragrance Association (CTFA).

36.

Occupational Health Services, Inc

. 1996. Material Safety Data Sheets database (MSDS-OHS). Nashville: STN International.

37.

Patil, M. A.

D. M. Mhatre

, and

N. M. Koshti

. 1989. Determination of sodium N-lauroyl sarcosinate by HPLC. Ind. J. Pharm. Sci.51:63–65.

38.

Rao, G. S.

, and

E. A. Bejnarowicz

. 1976. Thin-layer chromatography of sarcosine and its N-lauroyl and N-nitroso derivatives. J. Chromatogr.123:486–489.

39.

Rosenthal, M. W.

L. M. Marson

, and

A. Abriss

. 1954. Some laboratory observations on the chemical, bacterial and enzymatic properties of sodium N-lauroyl sarcosinate. J. Dent. Child.21L:194–201.

40.

Sax, N. I.

, ed. 1979. Dangerous properties of industrial materials, 5th ed., 822. New York: Van Nostrand Reinhold.

41.

Suspect Chemicals Sourcebook

. 1995. A Guide to Industrial Chemicals Covered Under Major Regulatory and Advisory Programs, vol. 1: Indexes. Bethesda, MD: Roytech Publications.

42.

Technology Sciences Group Inc

. 1994a. N-Acyl Sarcosines and Sodium N-Acyl Sarcosinates Administrative Volume and Overview of Petition. Unpublished data submitted by Hampshire Chemical Corp., 5-27–97. (11 pages.)2

43.

Technology Sciences Group Inc

. 1994b. N-Acyl Sarcosines and Sodium N-Acyl Sarcosinates Product Chemistry and Residue Chemistry. Unpublished data submitted by Hampshire Chemical Corp., 5-27–97. (142 pages.)2

44.

Technology Sciences Group Inc

. 1994c. N-Acyl Sarcosines and Sodium N-Acyl Sarcosinates Toxicology. Unpublished data submitted by Hampshire Chemical Corporation, 5-27–97. (94 pages.)2

45.

van der Valk

P. G. M.

J. P. Nater

, and

E. Bleumink

. 1984. Skin irritancy of surfactant s as assessed by water vapor loss measurements. J. Invest. Dermatol.82:291–293.

46.

Wenninger, J. A.

R. C. Canterbery

, and

G. N. McEwen

, Jr., eds. 2000. International cosmetic ingredient dictionary and handbook,

8th ed.

, vol. 1-2. Washington, DC: CTFA.